Approval of a cheap version of HIV-prevention shot lenacapavir raises hopes in low-income countries
The U.S. Food and Drug Administration has approved a generic version of the world's only twice-a-year shot to prevent HIV - a big step toward making the drug available inexpensively and more quickly in 120 low- and middle-income countries.
The U.S. Food and Drug Administration has given the green light to a generic version of the only twice-yearly HIV prevention shot. This approval is a significant move to increase affordable and rapid access to the drug. The aim is to make it available in 120 low- and middle-income countries.
- FDA approves generic version of HIV prevention shot.
- This is the world’s only twice-a-year HIV prevention shot.
- Goal is inexpensive and quicker availability in 120 low- and middle-income countries.
Write a comment